These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15915538)

  • 1. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
    J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial expression of a single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies.
    Mamalaki A; Trakas N; Tzartos SJ
    Eur J Immunol; 1993 Aug; 23(8):1839-45. PubMed ID: 8344344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
    Loutrari H; Kokla A; Tzartos SJ
    Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
    Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
    J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
    Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
    Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
    J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paratope- and framework-related cross-reactive idiotopes on anti-acetylcholine receptor antibodies.
    Verschuuren JJ; Graus YM; Tzartos SJ; van Breda Vriesman PJ; De Baets MH
    J Immunol; 1991 Feb; 146(3):941-8. PubMed ID: 1988504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
    Sophianos D; Tzartos SJ
    J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
    Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
    Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.